Search Results - "Valpione, Sara"

Refine Results
  1. 1

    The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival by Valpione, Sara, Mundra, Piyushkumar A., Galvani, Elena, Campana, Luca G., Lorigan, Paul, De Rosa, Francesco, Gupta, Avinash, Weightman, John, Mills, Sarah, Dhomen, Nathalie, Marais, Richard

    Published in Nature communications (02-07-2021)
    “…Tumor infiltration by T cells is paramount for effective anti-cancer immune responses. We hypothesized that the T cell receptor (TCR) repertoire of tumor…”
    Get full text
    Journal Article
  2. 2

    Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade by Valpione, Sara, Pasquali, Sandro, Campana, Luca Giovanni, Piccin, Luisa, Mocellin, Simone, Pigozzo, Jacopo, Chiarion-Sileni, Vanna

    Published in Journal of translational medicine (11-04-2018)
    “…Ipilimumab is a licensed immunotherapy for metastatic melanoma patients and, in the US, as adjuvant treatment for high risk melanoma radically resected. The…”
    Get full text
    Journal Article
  3. 3

    Depression in cancer: The many biobehavioral pathways driving tumor progression by Bortolato, Beatrice, Hyphantis, Thomas N., Valpione, Sara, Perini, Giulia, Maes, Michael, Morris, Gerwyn, Kubera, Marta, Köhler, Cristiano A., Fernandes, Brisa S., Stubbs, Brendon, Pavlidis, Nicholas, Carvalho, André F.

    Published in Cancer treatment reviews (01-01-2017)
    “…•Depression is highly prevalent among individuals with cancer.•Co-morbid depression may lead to a worse prognosis among cancer patients.•Evidence instantiates…”
    Get full text
    Journal Article
  4. 4

    Ultraviolet radiation drives mutations in a subset of mucosal melanomas by Mundra, Piyushkumar A., Dhomen, Nathalie, Rodrigues, Manuel, Mikkelsen, Lauge Hjorth, Cassoux, Nathalie, Brooks, Kelly, Valpione, Sara, Reis-Filho, Jorge S., Heegaard, Steffen, Stern, Marc-Henri, Roman-Roman, Sergio, Marais, Richard

    Published in Nature communications (11-01-2021)
    “…Although identified as the key environmental driver of common cutaneous melanoma, the role of ultraviolet radiation (UVR)-induced DNA damage in mucosal…”
    Get full text
    Journal Article
  5. 5

    Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy by Sasso, Maria Stella, Lollo, Giovanna, Pitorre, Marion, Solito, Samantha, Pinton, Laura, Valpione, Sara, Bastiat, Guillaume, Mandruzzato, Susanna, Bronte, Vincenzo, Marigo, Ilaria, Benoit, Jean-Pierre

    Published in Biomaterials (01-07-2016)
    “…Abstract Tumor-induced expansion of myeloid-derived suppressor cells (MDSCs) is known to impair the efficacy of cancer immunotherapy. Among pharmacological…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Basal cell carcinoma: 10-year experience with electrochemotherapy by Campana, Luca G, Marconato, Roberto, Valpione, Sara, Galuppo, Sara, Alaibac, Mauro, Rossi, Carlo R, Mocellin, Simone

    Published in Journal of translational medicine (31-05-2017)
    “…Electrochemotherapy (ECT), by combining manageable cytotoxic agents with short electric pulses, represents an effective palliative skin-directed therapy. The…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Recommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review by Campana, Luca G., Clover, A. James P., Valpione, Sara, Quaglino, Pietro, Gehl, Julie, Kunte, Christian, Snoj, Marko, Cemazar, Maja, Rossi, Carlo R., Miklavcic, Damijan, Sersa, Gregor

    Published in Radiology and oncology (01-03-2016)
    “…Electrochemotherapy is becoming a well-established treatment for malignancies of skin and non-skin origin and its use is widening across Europe. The technique…”
    Get full text
    Journal Article
  12. 12

    Development and external validation of a prognostic nomogram for metastatic uveal melanoma by Valpione, Sara, Moser, Justin C, Parrozzani, Raffaele, Bazzi, Marco, Mansfield, Aaron S, Mocellin, Simone, Pigozzo, Jacopo, Midena, Edoardo, Markovic, Svetomir N, Aliberti, Camillo, Campana, Luca G, Chiarion-Sileni, Vanna

    Published in PloS one (17-03-2015)
    “…Approximately 50% of patients with uveal melanoma (UM) will develop metastatic disease, usually involving the liver. The outcome of metastatic UM (mUM) is…”
    Get full text
    Journal Article
  13. 13

    Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib by Valpione, Sara, Campana, Luca G., Pigozzo, Jacopo, Chiarion-Sileni, Vanna

    Published in Radiology and oncology (01-03-2015)
    “…Background. Small molecules that inhibit V600 mutated BRAF protein, such as vemurafenib and dabrafenib, are effective in treatment of metastatic melanoma. Case…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Sequential immunotherapy regimens—expect the unexpected by Serra-Bellver, Patricio, Valpione, Sara, Lorigan, Paul

    Published in The lancet oncology (01-07-2016)
    “…PD-1 inhibitors (nivolumab and pembrolizumab) are well tolerated and associated with grade 3-4 adverse events in 10-15%1,2 of patients, between 36-44% of…”
    Get full text
    Journal Article
  19. 19

    Immune-awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy by Valpione, Sara, Galvani, Elena, Tweedy, Joshua, Mundra, Piyushkumar A, Banyard, Antonia, Middlehurst, Philippa, Barry, Jeff, Mills, Sarah, Salih, Zena, Weightman, John, Gupta, Avinash, Gremel, Gabriela, Baenke, Franziska, Dhomen, Nathalie, Lorigan, Paul C, Marais, Richard

    Published in Nature cancer (01-02-2020)
    “…Our understanding of how checkpoint inhibitors (CPI) affect T cell evolution is incomplete, limiting our ability to achieve full clinical benefit from these…”
    Get full text
    Journal Article
  20. 20